FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 12.8 milligram and ibuprofen 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely aluminium hydroxide 600 milligram and magnesium hydroxide 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzthiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 200 milligram and ritonavir 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 50 milligram/1 gram and levomenthol 30 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 2 milligram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely calcium carbonate 1.25 gram and colecalciferol 5 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely enalapril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clioquinol 10 milligram/1 milliliter and flumetasone pivalate 200 microgram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely captopril 25 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely paracetamol 150 milligram and sodium salicylate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 10 milligram and dequalinium chloride 250 microgram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release transdermal cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pseudoephedrine hydrochloride 60 milligram and triprolidine hydrochloride 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 2 milligram/1 gram and lidocaine hydrochloride 10 milligram/1 gram conventional release cutaneous spray Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and urea 100 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and losartan potassium 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only vitamin A 4000 iu and vitamin D 400 iu/1 each oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lauromacrogol 30 milligram/1 gram and urea 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and bumetanide 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram and clavulanic acid (as clavulanate potassium) 200 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 100 milligram and ergotamine tartrate 2 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 750 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol valerate 2 milligram and medroxyprogesterone 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 10 milligram/1 gram and nystatin 100000 unit/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely desogestrel 150 microgram and ethinylestradiol 20 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 28 of 35 Next End

    This concept is not in any reference sets

    Back to Start